Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors

Clinical trial NCT06943755 · RECRUITING

Trial details

NCT number: NCT06943755
Sponsor: Exelixis
Status: RECRUITING
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Pancreatic Neuroendocrine Tumor (pNET)Extra-Pancreatic Neuroendocrine Tumor (epNET)

Start date: 2025-07-21
Primary completion: 2029-06-30
Enrollment: 440

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.